🔺30 Outstanding Small Businesses of the Year 2025
Our Customers and Their Satisfaction is Our Responsibility: Michael Wolber of OCULUS, Inc.
By developing sophisticated technology-based instruments of the highest quality, OCULUS provides excellent support for the challenging daily tasks eye care professionals encounter.

Michael Wolber, President & CEO, Oculus, Inc.
OCULUS, Inc. is a leading provider of advanced diagnostic equipment and software solutions for eye care professionals. Founded in 1999, the company has earned a reputation as a trusted partner in optometry, offering products that enhance the accuracy, efficiency, and consistency of eye examinations. Headquartered in Arlington, Washington, OCULUS combines German engineering with dedicated customer support to deliver solutions that meet the evolving demands of modern eye care practices.
A Vision for Early Detection and Patient Education
OCULUS focuses on early detection and patient education. Michael Wolber, president and CEO, highlights that timely diagnosis of conditions such as myopia, dry eye, and keratoconus can dramatically improve treatment outcomes. “By identifying eye conditions early, practitioners can implement interventions that preserve vision and prevent complications,” Wolber says.
OCULUS equips eye care professionals with tools that combine precision and usability. The company’s diagnostic instruments and integrated software streamline clinical workflows, allowing practitioners to spend more time with patients while obtaining accurate, actionable insights. The technology is designed to complement, not replace, the judgment and expertise of clinicians.
Innovative Solutions for Modern Eye Care
OCULUS offers a comprehensive suite of diagnostic instruments and software applications. These solutions are developed in collaboration with practicing clinicians, ensuring that they are practical, reliable, and effective in real-world settings. From advanced imaging to dry eye assessment tools, OCULUS products help eye care professionals make informed clinical decisions and improve patient outcomes.
Beyond hardware, the company invests in proprietary software platforms that facilitate analysis, reporting, and patient communication. These platforms enable practitioners to integrate patient data seamlessly, track treatment progress, and provide personalized recommendations. “Our software amplifies the value of our instruments, allowing clinicians to translate data into better care,” Wolber explains.
Commitment to Customer Support and Education
OCULUS understands that technology alone is insufficient without guidance and support. The company provides comprehensive resources, including hands-on training programs, online workshops, and responsive customer service teams. Wolber notes, “Empowering professionals with knowledge is just as important as providing tools. When clinicians understand how to use our technology fully, patients benefit.”
The company also emphasizes continuing education, hosting webinars, clinical seminars, and practical training sessions. These initiatives ensure that practitioners stay current with industry advancements, regulatory changes, and emerging best practices.
Expanding Access to Comprehensive Eye Care
OCULUS is committed to making advanced diagnostics accessible to a broader range of eye care practices. By offering scalable solutions suitable for both small clinics and large multi-location practices, the company enables a diverse range of providers to enhance their services. Wolber highlights that this accessibility strengthens the overall quality of eye care in communities served.
A Culture of Collaboration and Innovation
Collaboration is key to OCULUS’ innovation. The company partners with researchers, clinicians, and technology developers to explore new approaches in diagnostics and patient care. Wolber believes that bringing together diverse perspectives accelerates innovation and ensures that solutions remain practical and clinically relevant.
The company’s internal culture mirrors this collaborative approach. Teams across engineering, product development, and customer support work closely to solve challenges and refine solutions. “Innovation at OCULUS is a team effort,” Wolber says. “Our people, culture, and dedication to excellence make it possible to deliver products that truly impact patient care.”
What’s Next for Oculus, Inc.
As the landscape of eye care evolves, OCULUS continues to invest in research and development, exploring emerging technologies such as AI-assisted diagnostics, advanced imaging, and predictive analytics. These innovations are intended to enhance early detection, improve patient outcomes, and enable practices to operate more efficiently.
Wolber emphasizes that the company’s vision extends beyond technology, “We aim to support clinicians in every aspect of their practice, from diagnosis to patient education, so they can deliver care that makes a real difference.”
OCULUS, Inc.’s dedication to innovation, early detection, and professional support positions it as a leader in eye care diagnostics. Under Michael Wolber’s leadership, the company has built a reputation for precision, reliability, and collaboration. By providing tools, knowledge, and resources, OCULUS empowers eye care professionals to deliver better outcomes for their patients while shaping the future of eye care.
Michael Wolber, President & CEO, OCULUS, Inc.
Our products, including the Pentacam®, Keratograph® 5M, and Easyfield® C, have set the gold standard in ophthalmic diagnostic devices.